Global Pharmaceutical Contract Manufacturing Organization Market Size study & Forecast, by Service Type (Active Pharmaceutical Ingredient Manufacturing, Finished Dosage Formulation Development and Manufacturing) and Regional Analysis, 2022-2029

Description

List of Tables

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Contract manufacturing is outsourcing where a manufacturer enters a formal agreement with another manufacturing company for its parts, goods, or components. A contract manufacturing organization (CMO) is an organization that caters to the pharmaceutical sector and offers clients entire services from manufacturing to drug research. CMOs provide services ranging from drug development, manufacturing, packaging, labeling, and distribution to their clients. Pharmaceutical clients can extend their technical resources by outsourcing to a CMO without incurring more overhead. By concentrating on core capabilities and high-value projects while decreasing or not increasing infrastructure or technical people, the client may manage its internal resources and costs. The business controls internal costs and resources by concentrating on core skills and high-value initiatives while decreasing or not increasing infrastructure or technical staff. The market growth is primarily driven by the factors such as surging demand for generic drugs, rising outsourcing volume by pharmaceutical companies, and increasing prevalence of various diseases.

In addition, the growing investment in research and development activities across the pharmaceutical industry is playing a significant role in market growth across the globe. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 198 billion and it is projected to reach around USD 248 billion by the year 2025. Consequentially, these aforementioned factors are propelling the market's development globally. Moreover, the rising number of government initiatives, as well as expansion in emerging countries are presenting various lucrative opportunities over the forecasting years. However, the stringent regulatory requirements and increasing lead time and logistics costs are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Contract Manufacturing Organization (CMO) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of clinical trials in the region, along with the presence of advanced manufacturing capabilities. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as favorable government policies, growing investment in R&D, as well as rising outsourcing volume by pharmaceutical companies in the market space.

Major market players included in this report are:

Catalent Inc.
Recipharm AB
Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim Group
Pfizer CentreSource (Pfizer Inc.)
Aenova Group
Famar SA
Baxter Biopharma Solutions (Baxter International Inc.)
Lonza Group AG

Recent Developments in the Market:

In March 2022, Sterling Drug Solutions UK, a global CDMO, and Novartis announced an agreement for Sterling to purchase Novartis' Ringaskiddy campus (formerly known as Novartis Ringaskiddy Limited) in Ireland. The company acquired the 111-acre site that involves three active pharmaceutical ingredient (API) manufacturing buildings, along with facilities to support the development and scale-up in line with Sterling's core business focus.
In March 2022, Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The upgrades increase the development laboratories' capacity and capabilities while enabling kilogram-scale production of highly potent APIs (HPAPIs), which have grown to play a significant role in the company's small-molecule development pipeline.

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Report Scope:

Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Service Type, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Service Type:

Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development and Manufacturing

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Dynamics

3.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising outsourcing volume by pharmaceutical companies
  - 3.1.1.2. Growing investment in research and development activities across the pharmaceutical industry
- 3.1.2. Market Challenges
  - 3.1.2.1. Stringent regulatory requirements
  - 3.1.2.2. Increasing lead time and logistics costs
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising number of government initiatives
  - 3.1.3.2. Expansion in emerging countries

Chapter 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, by Service Type

6.1. Market Snapshot
6.2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by Service Type, Performance - Potential Analysis
6.3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market Estimates & Forecasts by Service Type 2019-2029 (USD Billion)
6.4. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Sub Segment Analysis
- 6.4.1. Active Pharmaceutical Ingredient (API) Manufacturing
- 6.4.2. Finished Dosage Formulation (FDF) Development and Manufacturing

Chapter 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Analysis

7.1. Pharmaceutical Contract Manufacturing Organization (CMO) Market, Regional Market Snapshot
7.2. North America Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.2.1. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market
  - 7.2.1.1. Service Type breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.3. Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
- 7.3.1. U.K. Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.3.2. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.3.3. France Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.3.4. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.3.5. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.3.6. Rest of Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.4. Asia-Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
- 7.4.1. China Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.4.2. India Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.4.3. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.4.4. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.4.5. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.4.6. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.5. Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market Snapshot
- 7.5.1. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.5.2. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market
- 7.5.3. Rest of Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market
7.6. Rest of The World Pharmaceutical Contract Manufacturing Organization (CMO) Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. Catalent Inc.
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. Recipharm AB
- 8.2.3. Jubilant Biosys Ltd. (Jubilant Pharmova Ltd)
- 8.2.4. Patheon Inc. (Thermo Fisher Scientific Inc.)
- 8.2.5. Boehringer Ingelheim Group
- 8.2.6. Pfizer CentreSource (Pfizer Inc.)
- 8.2.7. Aenova Group
- 8.2.8. Famar SA
- 8.2.9. Baxter Biopharma Solutions (Baxter International Inc.)
- 8.2.10. Lonza Group AG

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, report scope
TABLE 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by Service Type 2019-2029 (USD Billion)
TABLE 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pharmaceutical Contract Manufacturing Organization (CMO) Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Pharmaceutical Contract Manufacturing Organization (CMO) Market
TABLE 69. List of primary sources, used in the study of global Pharmaceutical Contract Manufacturing Organization (CMO) Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, research methodology
FIG 2. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, key trends 2021
FIG 5. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, growth prospects 2022-2029
FIG 6. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, porters 5 force model
FIG 7. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, pest analysis
FIG 8. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, value chain analysis
FIG 9. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, regional snapshot 2019 & 2029
FIG 15. North America Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 16. Europe Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Pharmaceutical Contract Manufacturing Organization (CMO) Market 2019 & 2029 (USD Billion)
FIG 19. Global Pharmaceutical Contract Manufacturing Organization (CMO) Market, company Market share analysis (2021)